Camlin Fine Sciences Limited has received a regulatory disclosure from promoter Ashish S. Dandekar regarding the release of pledge on equity shares under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited on February 19, 2026.

Pledge Release Details

The promoter executed the release of pledge on 30,00,000 equity shares on February 18, 2026. This transaction represents a significant reduction in the encumbered shareholding of the promoter in the company.

Promoter Shareholding Structure

Ashish S. Dandekar's shareholding pattern shows his substantial stake in the company along with the encumbrance details before and after the pledge release.

Regulatory Compliance

The disclosure has been made in compliance with Regulation 31(1) and 31(2) of SEBI SAST Regulations. The promoter has submitted the required documentation to:

• BSE Limited (Scrip Code: 532834)
• National Stock Exchange of India Limited (Symbol: CAMLINFINE)
• Company Secretary of Camlin Fine Sciences Limited

This pledge release reduces the overall encumbered shareholding of the promoter from 5.21% to 3.65% of the company's total share capital, indicating a partial deleveraging of the promoter's stake in the company.

Camlin Fine Sciences Limited has released its investor presentation for Q3FY26 results discussion, revealing mixed operational performance amid strategic acquisitions and unforeseen challenges. The specialty chemicals company reported revenue growth while facing margin pressures and operational disruptions during the quarter ended December 31, 2025.

Financial Performance Overview

The company's Q3FY26 financial results demonstrated resilience in revenue generation despite challenging market conditions. Key performance metrics reflected both growth opportunities and operational headwinds.

Segment-wise Revenue Performance

The company's diversified product portfolio showed varied performance across different business segments during the quarter.

Specialty Ingredients Performance

The Straights business faced pricing pressure that impacted profitability, while the Value Added Blends segment maintained steady growth across key markets. Performance Chemicals revenue increased by 26.6% to Rs. 467.00 mn, while Aroma Ingredients declined by 4.2% to Rs. 547.00 mn during the quarter.

Strategic Acquisition and Operational Developments

Camlin Fine Sciences acquired a controlling stake of approximately 83.82% in Vinpai, a French company specializing in natural functional ingredients derived from algae, plants, minerals, and fibers. The acquisition contributed Rs. 129.00 mn in revenue during Q3FY26.

Vinpai Acquisition Highlights

The acquisition aligns with the company's strategy for portfolio diversification into natural ingredients, market expansion across 36+ countries, and enhanced R&D capabilities in functional ingredients.

Operational Challenges and Outlook

A significant operational challenge emerged with a fire incident reported at one unit in Brazil on February 7, 2026. Operations at the affected unit have been suspended, though the company's other Brazilian unit continues to operate. Loss assessment by insurers is in progress, and alternative arrangements are being made to service customers.

Additionally, CFS Europe is likely to be liquidated, which would help curtail losses from discontinued operations. The Vanillin business faced tariff-related challenges during the quarter but is expected to benefit from higher realizations on internal channel inventory following tariff withdrawal.

Regional Performance Analysis

The company's global operations showed mixed performance across different geographies during the nine-month period.

Conference Call and Regulatory Disclosure

Following the results announcement, the company conducted a conference call on February 13, 2026, to discuss the Q3FY26 unaudited financial results. The management team was represented by Mr. Ashish Dandekar, Chairman & Managing Director, Mr. Nirmal Momaya, Managing Director, and Mr. Santosh Parab, Chief Financial Officer.

The audio recording of the conference call is available on the company's website at the investor relations section. The company confirmed that discussions were based on publicly available information and no unpublished price sensitive information was discussed during the interactions.

Management Outlook

For the remaining financial year, management expects the Vanillin business to improve on both realizations and volume with the withdrawal of US tariffs. The Blends business is likely to maintain growth momentum across all geographies despite challenges in CFS Brazil. Employee costs and other expenses remain under control, though they increased due to the Vinpai acquisition during the quarter.